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COMP-Ang2(Ang2) produces more versatile and dynamic functions than angiopoietin-1
(Ang1) in angiogenesis and inﬂammation, the molecular mechanism that underlies this difference is still
unknown. To deﬁne the role of oligomerization of Ang2 in activation of its receptor, Tie2, we designed and
generated different oligomeric forms of Ang2 by replacement of the amino-terminal domains of Ang2 with
dimeric, tetrameric, and pentameric short coiled-coil domains derived from GCN4, matrillin-1, and COMP.
COMP-Ang2 strongly binds and activates Tie2, whereas GCN4-Ang2 and MAT-Ang2 weakly to moderately
bind and activate Tie2. Although native Ang2 strongly binds to Tie2, it does not activate Tie2. Accordingly,
COMP-Ang2 strongly promotes endothelial cell survival, migration, and tube formation in a Tie2-dependent
manner, and the potency of COMP-Ang2 is almost identical to that of COMP-Ang1. Furthermore, the potency
of COMP-Ang2-induced enhanced angiogenesis in the wound healing region is almost identical to the
potency of COMP-Ang1-induced enhanced angiogenesis. Overall, there is no obvious difference between
COMP-Ang2 and COMP-Ang1 in in vitro and in vivo angiogenesis. Our results provide compelling evidence
that proper oligomerization of Ang2 is a critical determinant of its binding and activation of Tie2.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The angiopoietin (Ang) family of growth factors, Ang1, Ang2,
Ang3 and Ang4, are secreted protein ligands of Tyrosine kinase with
Immunoglobulin and Epidermal growth factor homology domain 2
(Tie2) [1], which is mainly expressed in vascular endothelial cells
[2,3], hematopoietic stem cells [4,5] and a subset of monocytes/
macrophages [6]. The structure of all angiopoietins basically consists
of a carboxy-terminal ﬁbrinogen-like domain that is responsible for
receptor binding, a central coiled-coil domain that oligomerizes
these ﬁbrinogen-like domains, and a short amino-terminal domain
that superclusters these oligomers into variably-sized multimers
[1,7–10]. Despite the high similarity in structure among angiopoietins,
they have distinct physiological functions in angiogenesis, lymphan-
giogenesis, and inﬂammation [1,11–14]. Ang1 induces well-organized
angiogenesis as well as vascular stabilization by enhancing endothe-
lial integrity [9,15], whereas Ang2 induces more versatile and dynamic
functions depending on its environment [13]. For instance, Ang2
regresses and destabilizes blood vessels in the absence of VEGF, but
leads to robust angiogenesis in the presence of VEGF, speciﬁcally in
the context of tumor angiogenesis [16], transient vascular network+82 42 869 8160.
ll rights reserved.formation in the pupillary membrane of the developing eye [17], and
subcutaneous wound healing [14]. Moreover, Ang2 sensitizes
endothelial cells to TNF-α and has a crucial role in the induction of
inﬂammation [14,18,19]. In contrast, compelling evidence for an
antagonistic role of Ang2 on Ang1/Tie2 signaling in quiescent
endothelium was recently reported by the demonstration that
conditional transgenic overexpression of Ang2 in vascular endothelial
cells completely abolished Tie2 phosphorylation in vivo [20]. However,
the underlying molecular and cellular mechanisms leading to these
distinct roles of Ang1 and Ang2 are still poorly understood.
Oligomerization of the Tie2 receptor brings its kinase domains into
close proximity, thus allowing the kinase domains to phosphorylate
each other in trans. This process appears to be critical for Tie2
activation and Ang1/Tie2-induced endothelial integrity [21,22]. To
achieve Tie2 oligomerization and activation, Ang1 is assumed to use a
modular and multimeric structure unlike that of any other known
growth factor [8,10,23]. In fact, our previous rotary metal-shadowing
transmission electron microscopy (RMSTEM) analysis revealed that
Ang1 exists as heterogeneous multimers with basic trimeric, tetra-
meric, and pentameric oligomers, while Ang2 exists mainly as trimeric
and tetrameric oligomers [10]. These oligomers of Ang1 are able to
bind and activate Tie2 properly, whereas recombinantmonomeric and
dimeric Ang1 bind only weakly and are not able to activate Tie2 [9],
supporting the idea that proper oligomerization of Ang1 is required
for Tie2 oligomerization and activation. In contrast, oligomeric native
773H.-Z. Kim et al. / Biochimica et Biophysica Acta 1793 (2009) 772–780Ang2 binds strongly toTie2, but activates the receptor weakly or not at
all, suggesting that Ang2 may not be able to induce adequate Tie2
oligomerization. However, the molecular mechanism that underlies
this difference between Ang1 and Ang2 on Tie2 oligomerization and
activation is still unknown. Previously, we invented Ang1 variant,
COMP-Ang1, by replacement of the amino-terminus of Ang1 with the
short coiled-coil domain of cartilage oligomeric matrix protein
(COMP) [24]. COMP-Ang1 is more potent than native Ang1 in
phosphorylating the Tie2 receptor and signaling via Akt in primary
cultured endothelial cells [9] and in in vivo angiogenesis [25]. During
these studies, we learned that proper oligomerization of Ang1 is
necessary for producing its biological effects via Tie2. However, we do
not yet understand the role of proper oligomerization of Ang2 in Tie2
activation.
To deﬁne the role of oligomerization of Ang2 in Tie2 receptor
oligomerization and activation, we generated dimeric, tetrameric, and
pentameric Ang2 by replacement of the amino-terminal supercluster-
ing and coiled-coil domains with dimeric, tetrameric, and pentameric
short coiled-coil domains. Then we characterized the activities of
these constructs in binding and phosphorylating Tie2, and in
endothelial survival, migration, and tube formation in vitro. Because
pentameric Ang2 and pentameric Ang1 show similar effects in vitro,
we compared their angiogenic effects in a wound healing model. Our
results show that pentameric Ang2 is equivalent to pentameric Ang1
and shed light on the role of oligomerization of angiopoietin in the
activation of Tie2.
2. Materials and methods
2.1. Generation of recombinant Ang2 proteins
The pcDNA vector (Invitrogen) containing a secretory signal
sequence for hemagglutinin and a FLAG tag was used to construct the
coiled-coil domains of GCN4 [26], matrilin-1 (MAT) [27], or COMP
[10,24] fused to the linker and ﬁbrinogen-like domain (amino acid 258–
496) of Ang2 (GCN4-Ang2, MAT-Ang2, and COMP-Ang2, respectively).
The recombinant Ang2 proteins were produced by transient expression
of the gene constructs in human embryonic kidney 293 (HEK293) cells
(American Type Culture Collection) using Effectene liposomal transfec-
tion according to the manufacturer's instructions (Qiagen, Inc.). The
transfected HEK293 cells were maintained with Dulbecco's modiﬁed
Eagle's medium supplemented with 5% (v/v) heat-inactivated fetal
bovine serum at 37 °C in 5% CO2. The supernatant was harvested from
the transfected cells after 4 days, and the recombinant proteins
containing the FLAG sequence were puriﬁed using column chromato-
graphy on anti-FLAG M2 antibody agarose afﬁnity gel (Sigma) and
eluted with FLAG peptide (Sigma). After puriﬁcation, the recombinant
proteins were quantitated using the Bradford assay and conﬁrmedwith
Coomassie blue staining of an SDS-polyacrylamide gel. These analyses
showed that the yield was 400–500 μg of each recombinant protein per
liter of the HEK293 cell supernatant.
2.2. Transmission electron microscopy
The Ang2 recombinant proteins were negatively stained by uranyl
formate and imaged at room temperature in a Tecnai T120 microscope
(FEI) operated at 120 kV at a magniﬁcation of 52,000×. Images were
recorded on a 4 k×4 k UltraScan CCD camera (Gatan Inc.) with a
defocus of −1.5 μm. Particles were manually selected by using a
program Ximdisp, the display program associated with the MRC
program suite [28]. Image processing was performed using SPIDER
[29]. These particle imageswereﬁrst subjected to 10 rounds of standard
multi-reference alignment and classiﬁcation protocols specifying 40
classes [30]. Two unique averageswere selected from the resulting class
averages and used as references for another 10 cycles ofmulti-reference
alignment.2.3. Characterization of the recombinant proteins and Tie2 binding assay
SDS-PAGE analysis of proteins was performed under non-
reducing and reducing (heating for 10 min in 0.435 M β-
mercaptoethanol) conditions. Binding of the recombinant proteins
to the soluble extracellular domain of Tie1-Fc (sTie1-Fc, T1) or
Tie2-Fc (sTie2-Fc, T2) (R&D systems) was assayed using an in vitro
binding assay. Brieﬂy, each recombinant protein (100 ng) was
mixed with 500 ng of sTie1-Fc or sTie2-Fc and incubated in 500 μl
of Tris buffer solution (50 mM Tris, 100 mM NaCl, pH 7.4)
containing 0.02% Triton X-100 at 4 °C for 2 h. Then, 20 μl of
Protein-A agarose beads (Oncogene) was added and incubated for
another 1 h. The Protein-A-conjugated samples were washed twice
with 1 ml of Tris buffer containing 0.02% Triton X-100. The samples
were separated further by SDS-PAGE, electroblotted onto nitrocel-
lulose membranes, and probed with anti-FLAG M2 antibody
(Sigma).
2.4. Characterization of endogenous Ang2 secreted from primary
cultured HUVECs
Human umbilical vein endothelial cells (HUVECs) were pre-
pared from human umbilical cords by collagenase digestion and
maintained as described previously [31]. HUVECs were seeded at a
density of 1×106 cells/ml on gelatin coated dish. After cells were
incubated for 4 days in Endothelial Cell Basal Medium-2 (EBM-2)
supplemented with 5% FBS, supernatant media (∼40 ml) harvested
and pre-cleared with 20 μl of Protein-A agarose beads (Oncogene)
for 2 h at 4 °C. After 3 times of pre-clearing, 10 μg of sTie2-Fc was
added and incubated at 4 °C for 4 h, and then 50 μl of Protein-A
agarose beads added and incubated at 4 °C for 2 h. The Protein-A-
conjugated samples were washed twice with 1 ml of Tris buffer
containing 0.02% Triton X-100. The samples were separated further
by SDS-PAGE under non-reducing and reducing (heating for 10 min
in 0.435 M β-mercaptoethanol) conditions, electroblotted onto
nitrocellulose membranes, and probed with anti-Ang2 antibody
(R&D systems).
2.5. Tie2 and Akt phosphorylation assays
The primary cultured HUVECs used for this study were between
passages 2 and 3. To generate Tie2 expressing stable cells, a cDNA
fragment encoding full length Tie2 was cloned into the pCMV-dhfr2
vector, which includes the cytomegalovirus (CMV) promoter, dihy-
drofolate reductase (dhfr) gene, and neomycin-resistance gene. This
construct was used to generate a Tie2 expressing Chinese hamster
ovary cell line (CHO-Tie2) as previously described [32,33]. To generate
transient Tie2 expressing embryonic kidney 293 (HEK293) cells, 0.2,
1.0 and 5.0 μg of pCMV-dhfr2-Tie2 gene constructs were transfected
into HEK293 cells using Effectine (Qiagen). HUVECs and CHO-Tie2
were seeded in 100-mm dishes, whereas transient Tie2 expressing
HEK293 cells were incubated in serum containing medium for 48 h
after the transfection. When the cells became conﬂuent, they were
incubated with serum-free media for 12 h, and the medium was
changed to fresh serum-free medium. One hour later, the cells were
treated with the indicated proteins for 15 min (for Tie2 phosphoryla-
tion) or 30 min (for Akt phosphorylation). For Tie2 phosphorylation,
the cell lysates were immunoprecipitated with anti-Tie2 antibody
(R&D systems) and immunoblotted with anti-phosphotyrosine anti-
body (Upstate). Alternatively, for Akt phosphorylation, the cell lysates
were harvested, and 50 μg of total protein was loaded onto SDS-PAGE
and immunoblotted with anti-phospho-Akt (Ser473) antibody (Cell
Signaling). The membranes were stripped and reprobed with anti-
Tie2 antibody (Santa Cruz) or anti-Akt antibody (Cell Signaling) to
verify equal loading of protein. All signals were visualized and
analyzed by densitometric scanning (LAS-1000, Fuji Film).
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For the survival assay, conﬂuent HUVECs were incubated with
indicated proteins in serum freeM-199medium for 24 h. The cells were
photographed using a phase-contrastmicroscope, then stainedwith the
Annexin-V-FLUO staining kit (Roche Molecular Biochemicals, Man-
nheim, Germany) for 15 min at 20 °C. The stained cells were analyzed
on a ﬂow cytometer, and data were analyzed with CellQuest software
(Becton Dickinson). For the wound healing cell migration assay,
HUVECs were cultured to conﬂuence, and a scratch was made using a
sterile blue tip. Detached cells were removed, and dishes were treated
with the indicated protein for 24 h. Cells were photographed at 0 h and
24 h, and distances of migrationweremeasured. For the tube formation
assay, 200 μl of growth factor reducedMatrigel™ (BD Biosciences) were
loaded into a 24-well plate on ice and allowed to solidify for 30 min at
37 °C. HUVECs (∼5×104 cells) were resuspended in 1 ml of M-199
medium with the indicated proteins and seeded onto a Matrigel™Fig. 1. Protein structure analyses of native recombinant Ang2 and engineered Ang2 variants
(A2), GCN4-Ang2 (GA2), MAT-Ang2 (MA2), and COMP-Ang2 (CA2). Amino acids 1–18 are
(SCD), amino acids 71–257 are the coiled-coil oligomerization domain (CCOD), amino acid
domain (FLD) of Ang2. Ang2 contains cysteines (C) at amino acids 41, 54, 284, 313, 433, 435, 4
the short coiled-coil domains of GCN4, MAT, and COMP to generate oligomeric Ang2 varian
stained with Coomassie brilliant blue. Molecular masses (kDa) are indicated at left. (C) The o
bars= 10 nm. GCN4-Ang2, MAT-Ang2, and COMP-Ang2 form dimeric, tetrameric, and pen
primary cultured HUVECs. Arrows indicate different oligomeric forms of Ang2. Left bars in
(n=3∼4) show similar ﬁndings.coated well plate. After a 24-hour incubation at 37 °C, the cells were
photographed, and tube forming activities were quantiﬁed by measur-
ing tube-like structure lengths exceeding 50 μm per ﬁeld of 10 mm2.
2.7. In vivo angiogenesis assay
Recombinant adenoviruses expressing COMP-Ang2, COMP-Ang1,
Ang2, or β-galactosidase (β-gal) were constructed using the
pAdEasy vector system (Qbiogene) as previously described [25].
Speciﬁc pathogen-free FVB/N mice were purchased from Jackson
Laboratory (Jackson Labs, Bar Harbor, ME) and bred in our
pathogen-free animal facility. Male 7–8-week old mice were used
for this study. Animal care and experimental procedures were
performed under approval from the Animal Care Committees of
KAIST. For hole-punch assays, a 2.0-mm hole was made in the
center of both ears of the mouse using a metal ear punch (Harvard
Apparatus, Holliston). At 12 h after wounding, ∼1×109 pfu Ade-, and secreted endogenous Ang2 from HUVECs. (A) Schematic diagrams of native Ang2
the secretory signal sequence (S), amino acids 19–70 are the superclustering domain
s 258–281 are the linker region (L), and amino acids 282–496 are the ﬁbrinogen-like
37, and 450. The amino-terminal portion (amino acid 1–257) of Ang2 was replaced with
ts. (B) Reduced (R) and non-reduced (NR) proteins were separated by SDS-PAGE and
ligomeric states of recombinant proteins were imaged by the electron microscopy. Scale
tameric structures, respectively. (D) Immuno-blotting analysis of secreted Ang2 from
dicate molecular masses (kDa) shown in (B). Independent immuno-blotting analyses
Fig. 2. COMP-Ang2 activates Tie2/Akt signaling. (A) In vitro binding analyses of native
Ang2 (A2), GCN4-Ang2 (GA2), MAT-Ang2 (MA2), and COMP-Ang2 (CA2) with control
buffer (CB), sTie1-Fc (T1) and sTie2-Fc (T2). (B–E) Tie2 and Akt phosphorylation assays.
Serum-starved HUVECs CHO-Tie2 or transient Tie2 expressing HEK293 cells were
treated with control buffer (CB), indicated concentrations of CA2 or A2, or COMP-Ang1
(CA1) for 15 min, and Tie2 phosphorylation was measured. Serum-starved HUVECs
were treated with CB, A2 (400 ng/ml), and GA2, MA2, and CA2 (each 200 ng/ml) for
30 min, and the phosphorylation of Akt (Ser473) was measured. Fold, densitometric
analyses presented as the relative ratio of phospho-Tie2 (pTie2) or phospho-Akt (pAkt)
to Tie2 or Akt. The relative ratio of phospho-Tie2 to Tie2 or phospho-Akt to Akt with CB
is arbitrarily presented as 1. Numbers represent the mean (upper)±S.D. (lower) from
3–4 experiments. ⁎Pb0.05 versus CB.
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50 μl of sterile 0.9% NaCl was injected intravenously through the tail
vein. Circulating recombinant angiopoietins were measured by our
established enzyme-linked immunosorbent assay as previously
described [14]. At 2 weeks later, the mice were anesthetized with
80 mg/kg of ketamine hydrochloride and 12 mg/kg of xylazine,
perfused with 1% paraformaldehyde in PBS, and the ear skins were
harvested and immunostained as whole mounts. After blocking with
5% donkey serum in PBST (0.3% Triton X-100 in PBS) for 1 h at RT,
samples were incubated with anti-mouse PECAM-1 antibody,
hamster clone 2H8, 1:1000 (Chemicon International, Temecula,
CA). After several washes in PBST, the samples were incubated for
2 h at RT with Cy3-conjugated anti-hamster IgG antibody, 1:1,000
(Jackson ImmunoResearch). Fluorescent signals were visualized, and
digital images were obtained using a Zeiss LSM 510 confocal
microscope (Carl Zeiss). For each whole mount, blood vessel
densities were measured in each 0.2 mm2 region of the marginal
area and quantiﬁed using Image J software.
2.8. Statistics
Values presented are means±standard deviation (SD). Signiﬁcant
differences between means were determined by Student's t-test or
analysis of variance followed by the Student–Newman–Keuls test.
Statistical signiﬁcance was set at Pb0.05.
3. Results
3.1. Generation and analyses of designed oligomeric Ang2 variant proteins
We designed and generated Ang2 oligomeric variants as shown in
Fig. 1A. The corresponding variants were termed GCN4-Ang2, MAT-
Ang2, and COMP-Ang2. The recombinant proteins were analyzed on
SDS-PAGE under denaturing reducing conditions and non-reducing
conditions (Fig. 1B). Under reducing conditions, native Ang2 formed a
single band of the expected molecular size ∼65 kDa, whereas GCN4-
Ang2, MAT-Ang2, and COMP-Ang2 each formed a single band of ∼35–
40 kDa. Under non-reducing conditions, native recombinant Ang2
formed multimeric disulﬁde patterns, but it formed mainly a dimeric
form at ∼130 kDa and also higher-order oligomeric-forms with sizes
over 240 kDa.MAT-Ang2mainly formed adisulﬁde tetramer∼140 kDa,
and COMP-Ang2 formed mainly pentamer and hexamers at ∼180–
210 kDa, whereas GCN4-Ang2 formed monomeric Ang2 at ∼35–
40 kDa. To conﬁrm the oligomeric structures of the Ang2 variants,
images for themulti-reference alignedmolecules were captured using
negative staining electron microscopy [30]. The most frequent images
for GCN4-Ang2, MAT-Ang2, and COMP-Ang2 were dimers, tetramers,
and pentamers, respectively (Fig. 1C). In comparison, endogenous
Ang2 secreted from primary cultured HUVECs formed multimeric
disulﬁde patterns, but it formed mainly a dimeric form at ∼150–
160 kDa and also higher-order oligomeric-forms with sizes over
240 kDa under non-reducing condition on SDS-PAGE analysis (Fig.1D).
3.2. COMP-Ang2 binds and activates Tie2 receptor
In vitro binding analysis revealed that native Ang2 and COMP-Ang2
exhibited relatively strong binding to Tie2 (∼95% and ∼99% of total
input), whereas GCN4-Ang2 and MAT-Ang2 exhibited relatively low
binding to Tie2 (∼25% and ∼33% of total input) (Fig. 2A). However,
none of these Ang2 variant proteins bound to Tie1. These results
suggested that higher-order oligomerized forms of Ang2 have a higher
afﬁnity to Tie2, which is similar to the ﬁndings with several types of
oligomeric variants of Ang1 [9]. To compare the effect of native Ang2
and COMP-Ang2 onTie2 activation, the extent of Tie2 phosphorylation
was assayed in primary cultured HUVECs and CHO-Tie2 cells
(ectopically Tie2-expressing non-endothelial cells). In both cells, arelatively low concentration (0.2 μg/ml) of Ang2 slightly increased
Tie2 phosphorylation, whereas the half concentration of COMP-Ang2
markedly increased Tie2 phosphorylation in both HUVECs and CHO-
Tie2 cells (∼3.0-fold and ∼2.4-fold compared to 0.2 μg/ml of native
Ang2) (Fig. 2B and C). Even with a relatively high concentrations of
COMP-Ang2 (0.5 μg/ml) and Ang2 (1.0 μg/ml), COMP-Ang2-induced
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than Ang2-induced phosphorylation rates in both HUVECs and CHO-
Tie2 cells (Fig. 2B and C). In fact, expression of Tie2 at varied levels
in HEK293 cells resulted in barely detectable but similar levels of
Tie2 phosphorylation in the absence of COMP-Ang2 stimulation
(Fig. 2D). However, COMP-Ang2 induced marked Tie2 phosphoryla-
tion proportionate to the expression level of Tie2 (Fig. 2D).
Moreover, the COMP-Ang2-induced increase in Tie2 phosphorylation
was comparable to the COMP-Ang1-induced increase in Tie2
phosphorylation (Fig. 2B and C). Thus, proper oligomerization of
Ang2, rather than extent of Tie2 expression, is a critical determinant
of Tie2 activation. Akt signaling is a major route of downstream
signaling in Tie2-induced endothelial cell integrity and angiogenesis
[34]. Therefore, we tested the effect of the Ang2 variant proteins on
the extent of Akt (Ser473) phosphorylation in HUVECs. Akt (Ser473)
phosphorylation was increased 1.3-fold by Ang2, 1.4-fold by GCN4-
Ang2, 3.1-fold by MAT-Ang2, and 6.0-fold by COMP-Ang2, comparedFig. 3. COMP-Ang2 blocks endothelial cell apoptosis in a Tie2-dependent manner. (A) Repres
deprivation-induced endothelial cell apoptosis. HUVECs were incubated with 10% serum-
(400 ng/ml, A2), each Ang2 variant (200 ng/ml, GA2, MA2 and CA2), COMP-Ang1 (200 ng/m
ml, T2), A2+T2, CA2+T2 and CA1+T2 for 24 h. Note that the cells incubatedwith CA2 and C
T2 are the least adherent and the most ﬂoating. Scale bars, 0.5 mm. (B) Measurement of apop
from 4 experiments. ⁎Pb0.05 versus CB; φPb0.05 versus CA2 or CA1.to that of control buffer (Fig. 2E). Thus, COMP-Ang2 could be an
alternative to Ang1 or COMP-Ang1 at least in the activation of Tie2/
Akt signaling in endothelial cells.
3.3. COMP-Ang2 promotes endothelial cell survival, migration, and tube
formation in a Tie2-dependent manner
Activation of Tie2/Akt signaling is directly involved in endothe-
lial cell survival, migration, and tube formation [34]. Phase contrast
microscopic analysis revealed that, under serum starvation, a fair
number of ﬂoating dead cells were detected in HUVECS treated
with control buffer, Ang2, and GCN4-Ang2, whereas few ﬂoating
dead cells were detected after treatment with 10% serum, COMP-
Ang2, or COMP-Ang1 (Fig. 3A). In comparison, low numbers of
ﬂoating dead cells were detected in HUVECS treated with MAT-
Ang2 and Ang1 (Fig. 3A). The cell survival induced by COMP-Ang2
and COMP-Ang1 were largely abolished by adding an excess ofentative phase-contrast photographs for effects of Ang2 and Ang1 variants on the serum
containing medium (S10), serum-free medium with control buffer (CB), native Ang2
l, CA1) and native Ang1 (400 ng/ml, A1), and serum-free mediumwith sTie2-Fc (2 μg/
A1 are themost adherent and the least ﬂoating, whereas the cells incubatedwith CB and
tosis by Annexin-V immunostaining and ﬂow cytometry. Bars represent the mean±S.D.
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Analyses for cell apoptosis/survival using an Annexin-V staining
produced results (Fig. 3B and Supplementary Fig. 1) almost
identical to those obtained from the phase contrast microscopy.
An endothelial cell migration assay was performed by an assess-
ment of wound healing migration after making a scratch on
conﬂuent HUVECs [35] and incubating them with each recombinant
protein (Fig. 4A). The migration activity of the recombinant proteinsFig. 4. COMP-Ang2 profoundly induces endothelial cell migration. (A) Representative photog
scratch was made. Then the cells were treated with control buffer (CB), native Ang2 (400 ng
CA1), native Ang1 (400 ng/ml, A1), sTie2-Fc (2 μg/ml, T2), A2+T2, CA2+T2, and CA1+T2
migration starting points. Scale bars, 0.5 mm. (B) The extent of migration was quantiﬁed b
⁎Pb0.05 versus CB; #Pb0.05 versus A2; φPb0.05 versus A2, CA2 or CA1.were, in order, Ang2bGCN4-Ang2bMAT-Ang2=Ang1bCOMP-
Ang2bCOMP-Ang1 (Fig. 4B). The cell migration activities of
COMP-Ang1 and COMP-Ang2 were largely abolished by an excess
of sTie2-Fc (Fig. 4). We also stimulated HUVECs in Matrigel™ with
each recombinant protein for 24 h. COMP-Ang2 potently promoted
tube formation, and its potency was equivalent to COMP-Ang1, but
more than Ang1, MAT-Ang2, and Ang2, and its effect was totally
abolished by an excess of sTie2-Fc (Fig. 5A and B).raphs of the wound healing cell migration. HUVECs were cultured to conﬂuence, and a
/ml, A2), Ang2 variants (GA2, MA2 and CA2, each 200 ng/ml), COMP-Ang1 (200 ng/ml,
. Photographs were taken at 0 and 24 h after the wound scratch. Dashed lines indicate
y the distances of cell migration. Bars represent the mean±S.D. from 4 experiments.
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To examine the effect of COMP-Ang2 in angiogenesis in vivo, we
made a hole-punch injury in the ear of adult mice and treated them
with 1×109 pfu of Ade-β-gal (control), Ade-COMP-Ang2, Ade-Ang2,
or Ade-COMP-Ang1. The circulating plasma level of each recombinant
protein was measured at several time points over 2 weeks (Supple-
mentary Fig. 2). All circulating recombinant angiopoietins increased
similarly as early as 1 day after treatment, peaked at 3 to 5 days, and
declined gradually thereafter (Supplementary Fig. 2). The peak
concentrations of all 3 circulating angiopoietins were ∼3.0 to
3.5 μg/ml. All mice treated with any of the adenoviral constructs
appeared generally healthy and gained weight normally. The mice
treated with Ade-COMP-Ang2 exhibited profound increases in vessel
diameter and density in thewound healingmargin of the ear skin, and
its effects were higher (∼1.3 fold) than Ade-Ang2 but were equivalent
to Ade-COMP-Ang1 (Fig. 5C and D).Fig. 5. COMP-Ang2 stimulates tube formation of endothelial cells in vitro and promotes in vi
formation. HUVECs were seeded on Matrigel™ coated wells and treated with control buffer (
COMP-Ang1 (200 ng/ml, CA1), native Ang1 (400 ng/ml, A1), CA2+T2 and CA1+T2 for 24 h
tube length exceeding 50 μmper ﬁeld (10 mm2). Bars represent the mean±S.D. from 3–4 ex
angiogenesis induced by adenoviral COMP-Ang2 in wound healing ear skin. FVB/N mice wer
COMP-Ang1. Two weeks later, blood vessels at the healing margins were visualized with PE
COMP-Ang2 and Ade-COMP-Ang1 show increased vessel diameters and densities in ear skin.
and presented as a percentage of total blood vessels in the total area. Bars represent the mea
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the4. Discussion
Structure–function studies on oligomeric and multimeric ligands
provide an important clue about how they activate their receptors and
point to new directions to improve their activity by protein engineer-
ing. Here, we have designed and generated oligomeric Ang2 variant
proteins of GCN4-Ang2, MAT-Ang2 and COMP-Ang2 using a mamma-
lian cell expression system. Using SDS-PAGE, TEM, in vitro binding
assays, Tie2 phosphorylation assays, and in vitro and in vivo biological
assays, we provide a critical clue about the role of oligomerization and
function of Ang2.
The extracellular region of Tie2 contains two immunoglobulin-
like domains (Ig1 and Ig2), three epidermal growth factor-like
modules (3EGF), one immunoglobulin-like domain (Ig3), and three
ﬁbronectin type III (FNIII) repeats, in order from the amino-
terminus to the carboxy-terminus. Although the Ig2 of Tie2 has a
sole binding site to Ang1 and Ang2, a compact globular structurevo angiogenesis in wound healing ear skin. (A) Representative photographs of the tube
CB), native Ang2 (400 ng/ml, A2), Ang2 variants (GA2, MA2 and CA2, each 200 ng/ml),
. Scale bars, 2 mm. (B) Tube formation activities were quantiﬁed bymeasurement of total
periments. ⁎Pb0.05 versus CB; #Pb0.05 versus A2; φPb0.05 versus CA2 or CA1. (C) In vivo
e treated with 1×109 pfu of Ade-β-gal (control), Ade-COMP-Ang2, Ade-Ang2, and Ade-
CAM-1 (red) immunostaining. Scale bars, 100 μm. Note that the mice treated with Ade-
(D) Area densities of blood vessels were measured in each 0.2 mm2 in the marginal area
n±S.D. from 4 experiments. ⁎Pb0.05 versus Ade-β-gal. #Pb0.05 versus Ade-Ang2. (For
web version of this article.)
779H.-Z. Kim et al. / Biochimica et Biophysica Acta 1793 (2009) 772–780consisting of Ig1–Ig2–3EGF–Ig3 of Tie2 is necessary and sufﬁcient to
bind both Ang1 and Ang2 [36]. Recently, Barton et al. [37] showed
that the structure of the Ang2-Tie2 complex reveals an unusual
mode of interaction of receptor without major conformational
changes or domain rearrangements on its extracellular domain.
Thus, recognition of angiopoietin by Tie2 utilizes a lock-and-key
mechanism, in which they bind each other without marked
rearrangements. Likewise, the binding of COMP-Ang2 and MAT-
Ang2 to Tie2 may utilize a lock-and-key mechanism, in which they
bind each other without marked rearrangements in either binding
partner. Questions remain about how Ang1, COMP-Ang1, COMP-
Ang2, and MAT-Ang2 activate Tie2, while Ang2 does not activate
Tie2. The mechanistic basis of Tie2 phosphorylation upon ligand
activation is still not exactly known. One would imagine that Ang1–
Tie2 and Ang2–Tie2 interactions could produce different oligomer-
ization/multimerization states of Tie2, which might activate
different downstream signaling pathways for cellular responses.
Our results support why Ang1 and Ang2 produce different, even
opposing but sometimes similar, functions. The designed pentameric
Ang2, COMP-Ang2, produces almost identical effects, compared to
Ang1 and COMP-Ang1, on Tie2 phosphorylation, and on in vitro and
in vivo angiogenesis. Previously, we provided critical clues about the
structure–function relationship of Ang1 and Ang2. In order to
activate Tie2, oligomerization and multimerization of at least 4
subunits of Ang1 ligand are required [8,10]. Thus, the proper
oligomerization of Ang2 may be required to produce consistent
agonistic effects on Tie2 by promoting Tie2 clustering/oligomeriza-
tion, whereas improper oligomerization of Ang2 may act as an
antagonist on Tie2 by preoccupation to Tie2 without Tie2 cluster-
ing/oligomerization through inhibition of further binding of
properly oligomerized forms of Ang2 and Ang1.
Nevertheless, we still do not know about exact oligomerization
status of endogenous Ang2 in different tissues and under different
conditions. Based on SDS-PAGE analysis, previous studies have
shown that recombinant Ang2 is present as disulﬁde-linked
dimers [1,10,23,38]. However, our previous RMSTEM analysis
indicated that recombinant Ang2 was present mainly as trimers
and tetramers, plus a small fraction of higher order multimers [38].
Therefore, we believe that endogenous Ang2 exists as several types
of oligomers rather than simply as a dimer. Our present results
show that HUVECs secrete variable oligomeric forms of Ang2,
suggesting that endogenous Ang2 could consist of variable oligo-
meric forms. Therefore, the oligomerization status of the endogen-
ous secretory form of Ang2 needs to be elucidated by future studies
in order to distinguish the agonistic and antagonistic roles of Ang2
in vivo.
Ang1- or COMP-Ang1-induced activation of Tie2/Akt is a main
signaling pathway for survival, migration, and tube formation in
vascular endothelial cells [34]. The COMP-Ang2-induced promotion
of these processes could mainly be mediated through Tie2/Akt
because all these cellular effects are Tie2 dependent, and the effects
of COMP-Ang2 were identical to the effects of COMP-Ang1.
Furthermore, the COMP-Ang2-induced angiogenesis in the wound
healing region is almost identical to COMP-Ang1-induced promoted
angiogenesis. Thus, any obvious differences between COMP-Ang2
and COMP-Ang1 are not found in in vitro or in vivo angiogenesis,
supporting our mechanistic interpretation that the oligomerization
status of Ang2 is the critical determinant of the binding and
activation of Tie2.
Acknowledgments
We thank to Jennifer Macke for help in preparing the manuscript.
This work was supported by the Korea Research Foundation (R02-
2004-000-10120-0, GYK) and KOSEF (National Research Laboratory
Program, 2004-02376, GYK).Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.bbamcr.2009.01.018.
References
[1] G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, J. Holash, Vascular-
speciﬁc growth factors and blood vessel formation, Nature 407 (2000) 242–248.
[2] D.J. Dumont, T.P. Yamaguchi, R.A. Conlon, J. Rossant, M.L. Breitman, tek, a novel
tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial
cells and their presumptive precursors, Oncogene 7 (1992) 1471–1480.
[3] T.N. Sato, Y. Qin, C.A. Kozak, K.L. Audus, Tie-1 and tie-2 deﬁne another class of
putative receptor tyrosine kinase genes expressed in early embryonic vascular
system, Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 9355–9358.
[4] T.N. Sato, Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-
Maguire, T. Gridley, H. Wolburg, W. Risau, Y. Qin, Distinct roles of the receptor
tyrosine kinases Tie-1 and Tie-2 in blood vessel formation, Nature 376 (1995)
70–74.
[5] N. Takakura, T. Watanabe, S. Suenobu, Y. Yamada, T. Noda, Y. Ito, M. Satake, T. Suda,
A role for hematopoietic stem cells in promoting angiogenesis, Cell 102 (2000)
199–209.
[6] M. De Palma, M.A. Venneri, R. Galli, L. Sergi Sergi, L.S. Politi, M. Sampaolesi, L.
Naldini, Tie2 identiﬁes a hematopoietic lineage of proangiogenic monocytes
required for tumor vessel formation and a mesenchymal population of pericyte
progenitors, Cancer Cell 8 (2005) 211–226.
[7] S. Davis, T.H. Aldrich, P.F. Jones, A. Acheson, D.L. Compton, V. Jain, T.E. Ryan, J.
Bruno, C. Radziejewski, P.C. Maisonpierre, G.D. Yancopoulos, Isolation of
angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression
cloning, Cell 87 (1996) 1161–1169.
[8] S. Davis, N. Papadopoulos, T.H. Aldrich, P.C. Maisonpierre, T. Huang, L. Kovac, A. Xu,
R. Leidich, E. Radziejewska, A. Raﬁque, J. Goldberg, V. Jain, K. Bailey, M. Karow, J.
Fandl, S.J. Samuelsson, E. Ioffe, J.S. Rudge, T.J. Daly, C. Radziejewski, G.D.
Yancopoulos, Angiopoietins have distinct modular domains essential for receptor
binding, dimerization and superclustering, Nat. Struct. Biol. 10 (2003) 38–44.
[9] C.H. Cho, R.A. Kammerer, H.J. Lee, M.O. Steinmetz, Y.S. Ryu, S.H. Lee, K. Yasunaga,
K.T. Kim, I. Kim, H.H. Choi, W. Kim, S.H. Kim, S.K. Park, G.M. Lee, G.Y. Koh, COMP-
Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity, Proc.
Natl. Acad. Sci. U. S. A. 101 (2004) 5547–5552.
[10] K.T. Kim, H.H. Choi, M.O. Steinmetz, B. Maco, R.A. Kammerer, S.Y. Ahn, H.Z. Kim, G.M.
Lee, G.Y. Koh, Oligomerization andmultimerization are critical for angiopoietin-1 to
bind and phosphorylate Tie2, J. Biol. Chem. 280 (2005) 20126–20131.
[11] N.W. Gale, G. Thurston, S.F. Hackett, R. Renard, Q. Wang, J. McClain, C. Martin, C.
Witte, M.H. Witte, D. Jackson, C. Suri, P.A. Campochiaro, S.J. Wiegand, G.D.
Yancopoulos, Angiopoietin-2 is required for postnatal angiogenesis and lymphatic
patterning, and only the latter role is rescued by Angiopoietin-1, Dev. Cell 3 (2002)
411–423.
[12] H.J. Lee, C.H. Cho, S.J. Hwang, H.H. Choi, K.T. Kim, S.Y. Ahn, J.H. Kim, J.L. Oh, G.M.
Lee, G.Y. Koh, Biological characterization of angiopoietin-3 and angiopoietin-4,
FASEB J. 18 (2004) 1200–1208.
[13] U. Fiedler, H.G. Augustin, Angiopoietins: a link between angiogenesis and
inﬂammation, Trends Immunol. 27 (2006) 552–558.
[14] K.E. Kim, C.H. Cho, H.Z. Kim, P. Baluk, D.M. McDonald, G.Y. Koh, In vivo actions of
angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse
airways and skin, Arterioscler. Thromb. Vasc. Biol. 27 (2007) 564–570.
[15] G. Thurston, C. Suri, K. Smith, J. McClain, T.N. Sato, G.D. Yancopoulos, D.M.
McDonald, Leakage-resistant blood vessels in mice transgenically overexpressing
angiopoietin-1, Science 286 (1999) 2511–2514.
[16] J. Holash, P.C. Maisonpierre, D. Compton, P. Boland, C.R. Alexander, D. Zagzag, G.D.
Yancopoulos, S.J. Wiegand, Vessel cooption, regression, and growth in tumors
mediated by angiopoietins and VEGF, Science 284 (1999) 1994–1998.
[17] I.B. Lobov, P.C. Brooks, R.A. Lang, Angiopoietin-2 displays VEGF-dependent
modulation of capillary structure and endothelial cell survival in vivo, Proc.
Natl. Acad. Sci. U. S. A. 99 (2002) 11205–11210.
[18] U. Fiedler, Y. Reiss, M. Scharpfenecker, V. Grunow, S. Koidl, G. Thurston, N.W. Gale,
M. Witzenrath, S. Rosseau, N. Suttorp, A. Sobke, M. Herrmann, K.T. Preissner, P.
Vajkoczy, H.G. Augustin, Angiopoietin-2 sensitizes endothelial cells to TNF-alpha
and has a crucial role in the induction of inﬂammation, Nat. Med. 12 (2006)
235–239.
[19] V. Bhandari, R. Choo-Wing, C.G. Lee, Z. Zhu, J.H. Nedrelow, G.L. Chupp, X. Zhang,
M.A. Matthay, L.B. Ware, R.J. Homer, P.J. Lee, A. Geick, A.R. de Fougerolles, J.A.
Elias, Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic
cell death, Nat. Med. 12 (2006) 1286–1293.
[20] Y. Reiss, J. Droste, M. Heil, S. Tribulova, M.H. Schmidt, W. Schaper, D.J. Dumont, K.H.
Plate, Angiopoietin-2 impairs revascularization after limb ischemia, Circ. Res. 101
(2007) 88–96.
[21] S. Fukuhara, K. Sako, T. Minami, K. Noda, H.Z. Kim, T. Kodama, M. Shibuya, N.
Takakura, G.Y. Koh, N. Mochizuki, Differential function of Tie2 at cell–cell contacts
and cell–substratum contacts regulated by angiopoietin-1, Nat. Cell Biol. 10 (2008)
513–526.
[22] P. Saharinen, L. Eklund, J. Miettinen, R. Wirkkala, A. Anisimov, M. Winderlich, A.
Nottebaum, D. Vestweber, U. Deutsch, G.Y. Koh, B.R. Olsen, K. Alitalo, Angiopoie-
tins assemble distinct Tie2 signalling complexes in endothelial cell–cell and cell–
matrix contacts, Nat. Cell Biol. 10 (2008) 527–537.
780 H.-Z. Kim et al. / Biochimica et Biophysica Acta 1793 (2009) 772–780[23] W.N. Procopio, P.I. Pelavin, W.M. Lee, N.M. Yeilding, Angiopoietin-1 and-2
coiled coil domains mediate distinct homo-oligomerization patterns, but
ﬁbrinogen-like domains mediate ligand activity, J. Biol. Chem. 274 (1999)
30196–30201.
[24] V.N. Malashkevich, R.A. Kammerer, V.P. Eﬁmov, T. Schulthess, J. Engel, The crystal
structure of a ﬁve-stranded coiled coil in COMP: a prototype ion channel? Science
274 (1996) 761–765.
[25] C.H. Cho, K.E. Kim, J. Byun, H.S. Jang, D.K. Kim, P. Baluk, F. Baffert, G.M. Lee, N.
Mochizuki, J. Kim, B.H. Jeon, D.M. McDonald, G.Y. Koh, Long-term and sustained
COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood ﬂow,
Circ. Res. 97 (2005) 86–94.
[26] E.K. O'Shea, J.D. Klemm, P.S. Kim, T. Alber, X-ray structure of the GCN4 leucine
zipper, a two-stranded, parallel coiled coil, Science 254 (1991) 539–544.
[27] S.A. Dames, R.A. Kammerer, R. Wiltscheck, J. Engel, A.T. Alexandrescu, NMR
structure of a parallel homotrimeric coiled coil, Nat. Struct. Biol. 5 (1998)
687–691.
[28] F. Metoz, M.B. Sherman, M.F. Schmid, Adopting a database as a solution to
managing electron image data, J. Struct. Biol. 133 (2001) 170–175.
[29] J. Frank, M. Radermacher, P. Penczek, J. Zhu, Y. Li, M. Ladjadj, A. Leith, SPIDER and
WEB: processing and visualization of images in 3D electron microscopy and
related ﬁelds, J. Struct. Biol. 116 (1996) 190–199.
[30] M. Ohi, Y. Li, Y. Cheng, T.Walz, Negative staining and image classiﬁcation— powerful
tools in modern electron microscopy, Biol. Proced. Online 6 (2004) 23–34.[31] I. Kim, H.G. Kim, S.O. Moon, S.W. Chae, J.N. So, K.N. Koh, B.C. Ahn, G.Y. Koh,
Angiopoietin-1 induces endothelial cell sprouting through the activation of focal
adhesion kinase and plasmin secretion, Circ. Res. 86 (2000) 952–959.
[32] S.J. Hwang, H.H. Choi, K.T. Kim, H.J. Hong, G.Y. Koh, G.M. Lee, Expression and
puriﬁcation of recombinant human angiopoietin-2 produced in Chinese hamster
ovary cells, Protein Expr. Purif. 39 (2005) 175–183.
[33] S.J. Hwang, H.Z. Kim, G.Y. Koh, G.M. Lee, Expression and puriﬁcation of
recombinant human angiopoietin-1 produced in Chinese hamster ovary cells, In
Vitro Cell Dev. Biol. Anim. 43 (2007) 162–167.
[34] N. Jones, K. Iljin, D.J. Dumont, K. Alitalo, Tie receptors: newmodulators of angiogenic
and lymphangiogenic responses, Nat. Rev., Mol. Cell Biol. 2 (2001) 257–267.
[35] C.C. Liang, A.Y. Park, J.L. Guan, In vitro scratch assay: a convenient and inexpensive
method for analysis of cell migration in vitro, Nat. Protoc. 2 (2007) 329–333.
[36] U. Fiedler, T. Krissl, S. Koidl, C. Weiss, T. Koblizek, U. Deutsch, G. Martiny-Baron, D.
Marme, H.G. Augustin, Angiopoietin-1 and angiopoietin-2 share the same binding
domains in the Tie-2 receptor involving the ﬁrst Ig-like loop and the epidermal
growth factor-like repeats, J. Biol. Chem. 278 (2003) 1721–1727.
[37] W.A. Barton, D. Tzvetkova-Robev, E.P. Miranda, M.V. Kolev, K.R. Rajashankar, J.P.
Himanen, D.B. Nikolov, Crystal structures of the Tie2 receptor ectodomain and the
angiopoietin-2–Tie2 complex, Nat. Struct. Mol. Biol. 13 (2006) 524–532.
[38] I. Kim, J.H. Kim, Y.S. Ryu, S.H. Jung, J.J. Nah, G.Y. Koh, Characterization and
expression of a novel alternatively spliced human angiopoietin-2, J. Biol. Chem.
275 (2000) 18550–18556.
